News
The company hopes to stand out with Diabegone, a diabetes treatment that lasts longer than competing drugs from companies ...
ET Net News Agency, 12 August 2025] CSPC PHARMA (01093) fell 2.8% to HK$10.07. It hits an intra-day low of HK$10.02, and an intra-day high of HK$10.46. The total shares traded was 83.88 million, with ...
Madrigal Pharmaceuticals, Inc.'s Rezdiffra saw Q2 net sales soar 55% to $212.8M amid strong growth. EU approval expected by ...
Madrigal Pharma secures global rights to SYH2086, a GLP-1 receptor agonist. Read more here.
Madrigal Pharmaceuticals has agreed to enter into a global license agreement with CSPC Pharmaceutical Group Limited for its preclinical oral small molecule glucagon-like-peptide-1 (GLP-1) receptor ...
Madrigal Pharmaceuticals Inc. and CSPC Pharmaceutical Group Ltd. have entered into an exclusive global license agreement for CSPC’s SYH-2086, a preclinical oral small-molecule glucagon-like peptide-1 ...
Madrigal Pharmaceuticals Inc. and CSPC Pharmaceutical Group Ltd. have entered into an exclusive global license agreement for CSPC’s SYH-2086, a preclinical oral small-molecule glucagon-like peptide-1 ...
U.S. drugmaker Madrigal Pharmaceuticals has struck a licensing deal with CSPC Pharmaceutical Group that could be worth more than $2 billion for the Chinese company if it results in a new drug for ...
3d
TipRanks on MSNCSPC Innovation Reports Revenue Growth Amidst Profitability Challenges
CSPC Pharmaceutical Group ( ($HK:1093) ) has issued an announcement. CSPC Innovation Pharmaceutical Co., Ltd., a subsidiary of CSPC Pharmaceutical ...
Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited Provided by GlobeNewswire Jul 30, 2025, 2:00:00 AM ...
Financial Considerations Under the agreement, CSPC has granted Madrigal an exclusive global license to develop, manufacture, and commercialize SYH2086.
Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited Read Next Aurora Mobile’s GPTBots.ai to Integrate Zhipu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results